Renaissance Technologies LLC Purchases New Shares in Teleflex Incorporated $TFX

Renaissance Technologies LLC purchased a new position in Teleflex Incorporated (NYSE:TFX) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 56,700 shares of the medical technology company’s stock, valued at approximately $6,782,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. GC Wealth Management RIA LLC purchased a new stake in shares of Teleflex in the first quarter valued at $1,492,000. Systematic Financial Management LP purchased a new position in shares of Teleflex during the 1st quarter worth about $1,922,000. PNC Financial Services Group Inc. boosted its stake in shares of Teleflex by 11.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 17,346 shares of the medical technology company’s stock worth $2,075,000 after purchasing an additional 1,759 shares during the period. Heartland Advisors Inc. grew its holdings in Teleflex by 107.8% during the 1st quarter. Heartland Advisors Inc. now owns 215,998 shares of the medical technology company’s stock valued at $25,836,000 after purchasing an additional 112,071 shares during the last quarter. Finally, Bessemer Group Inc. grew its holdings in Teleflex by 30.5% during the 1st quarter. Bessemer Group Inc. now owns 47,798 shares of the medical technology company’s stock valued at $5,718,000 after purchasing an additional 11,180 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Trading Up 0.3%

Shares of TFX opened at $140.06 on Wednesday. The firm has a market capitalization of $6.20 billion, a price-to-earnings ratio of -6.14, a PEG ratio of 1.04 and a beta of 0.81. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $144.19. The company has a 50-day moving average of $131.27 and a 200 day moving average of $121.97.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The business had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company’s revenue for the quarter was up 32.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, research analysts expect that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, May 25th were paid a $0.34 dividend. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio is -5.96%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on TFX. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 28th. Bank of America upgraded Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target on the stock in a report on Monday, April 13th. Wall Street Zen lowered Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday. Needham & Company LLC boosted their price objective on Teleflex from $147.00 to $159.00 and gave the company a “buy” rating in a report on Friday. Finally, Wells Fargo & Company upped their price objective on Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $148.90.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.